Retractable Technologies, Inc. (NYSE MKT: RVP) announced that on April
20, 2015, the Supreme Court of the United States denied the petition for
a writ of certiorari by Becton, Dickinson and Company (“BD”) relating to
its Rule 60(b) motion in the portion of Retractable’s case against BD
addressing patent infringement claims.
The patent claims were severed from Retractable’s other claims against
BD in 2008. The other portion of the case in which the District Court
granted Retractable a final judgment for $352 million plus other relief
is not directly affected by the recent Supreme Court ruling.
Retractable manufactures and markets VanishPoint® and Patient
Safe® safety medical products. The VanishPoint® syringe,
blood collection, and IV catheter products are designed to prevent
needlestick injuries and product reuse by retracting the needle directly
from the patient, effectively reducing exposure to the contaminated
needle. Patient Safe® syringes are uniquely designed to
reduce the risk of bloodstream infections resulting from catheter hub
contamination. Retractable's products are distributed by various
specialty and general line distributors.
For more information on Retractable, visit our website at www.vanishpoint.com.
Forward-looking statements in this press release are made pursuant to
the safe harbor provision of the Private Securities Litigation Reform
Act of 1995 and reflect our current views with respect to future events.
We believe that the expectations reflected in such forward-looking
statements are accurate. However, we cannot assure you that such
expectations will materialize. Our actual future performance could
differ materially from such statements.
Factors that could cause or contribute to such differences include, but
are not limited to: our ability to maintain liquidity; our maintenance
of patent protection; the impact of current and future Court decisions
regarding current litigation; our ability to maintain favorable third
party manufacturing and supplier arrangements and relationships; our
ability to quickly increase capacity in response to an increase in
demand; our ability to access the market; our ability to maintain or
lower production costs; our ability to continue to finance research and
development as well as operations and expansion of production; the
impact of larger market players, specifically Becton, Dickinson and
Company, in providing devices to the safety market; and other risks and
uncertainties that are detailed from time to time in Retractable's
periodic reports filed with the U.S. Securities and Exchange Commission.
Copyright Business Wire 2015